A copy of this preliminary prospectus has been filed with the securities regulatory authorities in the provinces of British Columbia and Alberta but has not yet become final for the purpose of the sale of securities. Information contained in this preliminary prospectus may not be complete and may have to be amended. The securities may not be sold until a receipt for the prospectus is obtained from the securities regulatory authorities.

No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any securities. This non-offering prospectus does not constitute a public offering of securities.

PRELIMINARY PROSPECTUS

Non-Offering Prospectus

June 25, 2021

TELESCOPE INNOVATIONS CORP.

No securities are being offered pursuant to this prospectus

This non-offering prospectus (the "Prospectus") is being filed with the British Columbia Securities Commission and the Alberta Securities Commission for the purpose of allowing Telescope Innovations Corp. ("Telescope" or the "Company") to comply with Policy 2 - Qualifications for Listing of the Canadian Securities Exchange ("CSE" or the "Exchange") in order for the Company to meet one of the eligibility requirements for the listing of Telescope's common shares (the "Common Shares") on the Exchange. Since no securities are being sold pursuant to this Prospectus, no proceeds will be raised, and all expenses incurred in connection with the preparation and filing of this Prospectus will be paid by the Company from its general funds.

There is no market through which any securities of the Company may be sold and holders of the Company's securities may not be able to resell any such securities. This may affect the pricing of the securities in the secondary market, the transparency and availability of trading prices, the liquidity of the securities, and the extent of issuer regulation.

No underwriter has been involved in the preparation of this Prospectus or performed any review or independent due diligence investigations in respect of the contents of this Prospectus.

The Company has applied to list its Common Shares on the CSE. The CSE has not approved the listing of the Common Shares. Listing will be subject to the Company fulfilling all of the requirements of the CSE, including meeting all minimum listing requirements. There is no guarantee that the CSE will provide approval for the listing of the Common Shares. As at the date of this Prospectus, the Company does not have any of its securities listed or quoted, has not applied to list or quote any of its securities, and does not intend to apply to list or quote any of its securities, on the Toronto Stock Exchange, Aequitas NEO Exchange Inc., a U.S. marketplace, or a marketplace outside Canada and the United States of America.

An investment in the Common Shares of the Company is speculative and involves a high degree of risk and should only be made by persons who can afford the total loss of their investment. There is no guarantee that an investment in the Company will earn any positive return in the short or long term.

Prospective investors should consider certain risk factors in connection with an investment in the Company. See "Statement Regarding Forward-LookingInformation" and "Risk Factors".

No person has been authorized to provide any information or to make any representation not contained in this Prospectus and, if provided or made, such information or representation should not be relied upon. The information contained in this Prospectus is accurate only as of the date of this Prospectus.

This Prospectus does not constitute an offer to sell or the solicitation of an offer to buy any securities.

The registered and head office of the Company is 1600 - 609 Granville Street, Vancouver, British Columbia V7Y 1C3.

ii

TABLE OF CONTENTS

GLOSSARY ............................................................................................................................................

5

NOTE TO INVESTORS ............................................................................................................................

7

TRADEMARKS, TRADE NAMES AND SERVICE MARKS ............................................................................

8

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION .................................................

8

SUMMARY OF PROSPECTUS ...............................................................................................................

12

The Company ..........................................................................................................................................

12

Proceeds ..................................................................................................................................................

12

Total Available Funds and Principal Purposes .......................................................................................

12

Risk Factors.............................................................................................................................................

13

Selected Financial Information ...............................................................................................................

13

Financial Statements ...............................................................................................................................

14

CORPORATE STRUCTURE....................................................................................................................

16

Name, Address and Incorporation...........................................................................................................

16

Intercorporate Relationships ...................................................................................................................

16

GENERAL DEVELOPMENT AND DESCRIPTION OF THE BUSINESS OF THE COMPANY ............................

16

Intellectual Property ................................................................................................................................

21

Government Regulations.........................................................................................................................

23

Facilities ..................................................................................................................................................

24

Employees ...............................................................................................................................................

24

USE OF AVAILABLE FUNDS..................................................................................................................

25

Proceeds ..................................................................................................................................................

25

Total Available Funds and Principal Purposes .......................................................................................

25

Business Objectives and Milestones .......................................................................................................

26

DIVIDEND POLICY ...............................................................................................................................

27

SELECTED FINANCIAL INFORMATION AND MANAGEMENT'S DISCUSSION AND ANALYSIS...................

27

Selected Financial Information ...............................................................................................................

27

Management Discussion and Analysis of the Company .........................................................................

28

Selected Financial Information ...............................................................................................................

29

Management Discussion and Analysis of ClearMynd ............................................................................

29

DESCRIPTION OF THE SECURITIES OF THE COMPANY..........................................................................

30

Authorized and Issued Share Capital ......................................................................................................

30

Common Shares ......................................................................................................................................

30

CONSOLIDATED CAPITALIZATION .......................................................................................................

31

OPTIONS TO PURCHASE SECURITIES ...................................................................................................

31

Stock Option Plan ...................................................................................................................................

31

PRIOR SALES.......................................................................................................................................

32

ESCROWED SECURITIES AND SECURITIES SUBJECT TO RESTRICTION ON TRANSFER ............................

32

PRINCIPAL SECURITYHOLDERS............................................................................................................

34

DIRECTORS AND EXECUTIVE OFFICERS................................................................................................

34

Name, Occupation, and Security Holdings .............................................................................................

34

Director and Executive Officer Biographies ...........................................................................................

36

Cease Trade Orders, Bankruptcies, Penalties or Sanctions.....................................................................

38

Conflicts of Interest.................................................................................................................................

38

Term of Office of Directors ....................................................................................................................

39

Indemnification and Insurance ................................................................................................................

39

3

EXECUTIVE COMPENSATION...............................................................................................................

39

Compensation Governance .....................................................................................................................

39

Directors' and Officers' Liability Insurance and Indemnification ..........................................................

43

INDEBTEDNESS OF DIRECTORS AND EXECUTIVE OFFICERS ..................................................................

43

AUDIT COMMITTEE ............................................................................................................................

43

Relevant Education and Experience........................................................................................................

44

Pre-Approval Policies and Procedures....................................................................................................

45

Reliance on Certain Exemptions .............................................................................................................

45

External Auditor Service Fees by Category............................................................................................

45

Exemption ...............................................................................................................................................

46

CORPORATE GOVERNANCE ................................................................................................................

46

Board of Directors...................................................................................................................................

46

Directorships ...........................................................................................................................................

47

Orientation and Continuing Education....................................................................................................

47

Ethical Business Conduct........................................................................................................................

47

Nomination of Directors .........................................................................................................................

48

Compensation..........................................................................................................................................

48

Other Board Committees.........................................................................................................................

48

Director Assessment................................................................................................................................

48

PLAN OF DISTRIBUTION......................................................................................................................

48

RISK FACTORS ....................................................................................................................................

49

Risks Related to this Prospectus .............................................................................................................

49

Risks Related to the Company ................................................................................................................

52

Risks Related to Our Intellectual Property..............................................................................................

61

PROMOTERS ......................................................................................................................................

67

LEGAL PROCEEDINGS AND REGULATORY ACTIONS .............................................................................

67

Legal Proceedings ...................................................................................................................................

67

Regulatory Actions..................................................................................................................................

67

INTERESTS OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS ........................................

67

AUDITOR, TRANSFER AGENT AND REGISTRAR ....................................................................................

68

MATERIAL CONTRACTS ......................................................................................................................

68

EXPERTS .............................................................................................................................................

68

OTHER MATERIAL FACTS ....................................................................................................................

69

FINANCIAL STATEMENT DISCLOSURE..................................................................................................

69

LIST OF EXEMPTIONS FROM INSTRUMENT .........................................................................................

69

SCHEDULE "A" FINANCIAL STATEMENTS OF THE COMPANY ...............................................................

70

SCHEDULE "B" MD&A OF THE COMPANY ...........................................................................................

71

SCHEDULE "C" FINANCIAL STATEMENTS OF CLEARMYND ...................................................................

72

SCHEDULE "D" MD&A OF CLEARMYND...............................................................................................

73

SCHEDULE "E" PRO FORMA FINANCIAL STATEMENTS.........................................................................

74

SCHEDULE "F" AUDIT COMMITTEE CHARTER ......................................................................................

75

CERTIFICATE OF THE CORPORATION...................................................................................................

83

CERTIFICATE OF THE PROMOTERS ......................................................................................................

84

4

GLOSSARY

In this Prospectus, the following capitalized terms have the following meanings, in addition to other terms defined elsewhere in this Prospectus.

"Articles" means the articles of the Company.

"Audit Committee" means the Audit Committee of the Board.

"BCBCA" means the Business Corporations Act (British Columbia).

"Board" or "Board of Directors" means the board of directors of the Company.

"CEO" means the Chief Executive Officer of the Company.

"CFO" means the Chief Financial Officer of the Company.

"ClearMynd" means ClearMynd Technology Solutions Corp.

"ClearMynd Shares" means common shares in the capital of ClearMynd.

"Common Shares" means the common shares in the capital of the Company.

"Consolidation" means the consolidation of the Company's Common Shares on a two (old) for one (new) basis.

"CSE" or "Exchange" means the Canadian Securities Exchange.

"ECC" means ECC Diversified Inc.;

"Escrow Agent" means Odyssey Trust Company.

"IFRS" means the International Financial Reporting Standards as issued by the International Accounting Standards Board and the interpretations thereof by the International Financial Reporting Interpretations Committee and the former Standing Interpretations Committee.

"Insider" means a director or senior officer of the Company; a director or senior officer of a company that is an insider or subsidiary of the Company; a person that beneficially owns, directly or indirectly, or controls or has direction over, or a combination of such ownership and control and direction over, voting shares carrying more than 10% of the voting rights attached to all outstanding voting shares of the Company; or the Company itself if it holds any of its own securities.

"Listing Date" means the date the Company's Common Shares are first listed for trading on the Exchange.

"MD&A" means management's discussion and analysis.

"NEO" has the meaning ascribed to such term under "Director and Executive Compensation".

"NI 41-101" means National Instrument 41-101 - General Prospectus Requirements.

"NI 52-110" means National Instrument 52-110 - Audit Committees.

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Telescope Innovations Corp. published this content on 26 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 July 2022 20:09:38 UTC.